Testing effectiveness (Phase 2)Study completedNCT00628251
What this trial is testing
Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer
Who this might be right for
Ovarian Neoplasms
AstraZeneca 97